NASDAQ$OMCL
Omnicell Inc. · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Omnicell's third quarter performance in 2022 was affected by headwinds in point of care products, driven by health system capital budget freezes and customer labor availability challenges.
Omnicell's Q3 2022 GAAP revenues reached $348 million, a 17% increase from Q3 2021. GAAP net income was $17 million, or $0.37 per diluted share, compared to $29 million, or $0.61 per diluted share, in Q3 2021. The company experienced headwinds in point of care products due to capital budget freezes and labor challenges, but saw strong demand for Advanced Services and a record number of Central Pharmacy Dispensing Systems installations.
- GAAP and non-GAAP revenues of $348 million.
- GAAP net income per diluted share of $0.37.
- Non-GAAP net income per diluted share of $1.00.
- Experienced headwinds in point of care products due to health system capital budget freezes and customer labor availability challenges.
Headline financials
Revenue & EPS history
Omnicell · Revenue · Quarterly
$348M
Revenue by segment
Omnicell · $247M total across 1 segment · Q3 2022
- Product revenues$247M+15.2%100.0%
Forward guidance
For Q4 2022, Omnicell expects total GAAP and non-GAAP revenues between $285 million and $295 million, GAAP and non-GAAP product revenues between $183 million and $188 million, GAAP and non-GAAP service revenues between $102 million and $107 million, non-GAAP EBITDA between $10 million and $16 million, and non-GAAP earnings between $0.05 and $0.15 per share.
Tailwinds
- Total GAAP and Non-GAAP Revenues between $285 million and $295 million
- GAAP and Non-GAAP Product Revenues between $183 million and $188 million
- GAAP and Non-GAAP Service Revenues between $102 million and $107 million
Headwinds
- Non-GAAP EBITDA between $10 million and $16 million
- Non-GAAP Earnings Per Share between $0.05 and $0.15
- Guidance adjusted to include anticipated contributions and integration costs of recent acquisitions
- Guidance adjusted to include the anticipated effects of the current inflationary environment
- Guidance adjusted to include expected impact of current macro-economic headwinds
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
+0.7%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+4.7%
Avg return
30 days after
55%
36 / 65 earnings
Positive
+34.3%
Q2 2024
Best reaction
-29.4%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +13.7% | +18.8% | |
| Q4 2025 | -16.3% | -16.5% | -11.5% | |
| Q3 2025 | +13.4% | +16.7% | +23.5% | |
| Q1 2025 | -16.0% | -15.4% | +1.2% | |
| Q4 2024 | -11.2% | -7.1% | -16.7% | |
| Q3 2024 | +21.2% | +20.9% | +16.1% | |
| Q2 2024 | +34.3% | +41.6% | +52.3% | |
| Q1 2024 | +10.9% | +11.5% | +19.9% | |
| Q4 2023 | -15.6% | -11.9% | -12.0% | |
| Q3 2023 | -14.9% | -13.9% | -5.5% | |
| Q2 2023 | +2.3% | +2.9% | -10.0% | |
| Q1 2023 | +8.9% | +7.1% | +18.6% | |
| Q4 2022 | +7.9% | +6.6% | +6.4% | |
| Q3 2022 | -29.4% | -35.9% | -33.4% | |
| Q2 2022 | -2.1% | -5.6% | -10.6% | |
| Q1 2022 | +1.2% | +5.9% | +4.7% | |
| Q4 2021 | -9.6% | -18.4% | -11.5% | |
| Q3 2021 | +2.2% | +1.6% | +1.5% | |
| Q2 2021 | -1.1% | +0.4% | +7.1% | |
| Q1 2021 | +1.8% | -1.5% | -2.4% | |
| Q4 2020 | +7.0% | +8.9% | +6.5% | |
| Q3 2020 | +2.3% | +2.9% | +27.0% | |
| Q2 2020 | +9.1% | +5.5% | +2.7% | |
| Q1 2020 | -6.1% | -12.3% | -0.5% | |
| Q4 2019 | -1.4% | +2.3% | -4.5% | |
| Q3 2019 | -3.7% | -1.9% | +7.4% | |
| Q2 2019 | +6.7% | +5.4% | +0.6% | |
| Q1 2019 | +0.7% | +3.8% | +4.7% | |
| Q4 2018 | +17.9% | +21.0% | +28.0% | |
| Q3 2018 | +6.1% | +15.2% | +18.8% | |
| Q2 2018 | +13.7% | +13.0% | +29.5% | |
| Q1 2018 | +1.6% | -0.1% | +5.3% | |
| Q4 2017 | -6.2% | -9.8% | -12.9% | |
| Q3 2017 | -6.4% | -8.2% | -7.6% | |
| Q2 2017 | +12.5% | +16.3% | +12.1% | |
| Q1 2017 | -3.2% | -1.7% | +0.0% | |
| Q4 2016 | -0.7% | +1.0% | +4.5% | |
| Q3 2016 | -6.3% | -6.8% | +3.2% | |
| Q2 2016 | +6.8% | +4.7% | +3.4% | |
| Q1 2016 | +3.9% | — | — | |
| Q4 2015 | -1.0% | — | — | |
| Q3 2015 | -10.5% | — | — | |
| Q2 2015 | -8.8% | — | — | |
| Q1 2015 | -2.6% | — | — | |
| Q4 2014 | +5.3% | — | — | |
| Q3 2014 | +9.7% | — | — | |
| Q2 2014 | -3.9% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2013 | +8.9% | — | — | |
| Q3 2013 | -1.4% | — | — | |
| Q2 2013 | +8.7% | — | — | |
| Q1 2013 | +7.6% | — | — | |
| Q3 2010 | -1.3% | — | — | |
| Q4 2012 | +13.4% | — | — | |
| Q3 2012 | +12.2% | — | — | |
| Q2 2012 | +0.9% | — | — | |
| Q1 2011 | -0.3% | — | — | |
| Q1 2012 | +4.8% | — | — | |
| Q4 2011 | +2.6% | — | — | |
| Q4 2009 | +2.6% | — | — | |
| Q3 2011 | -0.7% | — | — | |
| Q2 2010 | -16.9% | — | — | |
| Q2 2011 | -16.9% | — | — | |
| Q4 2010 | -16.9% | — | — | |
| Q1 2010 | +7.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro